Table 1.

The inhibitory effect of CF and positive control EA on the proliferation of B-MD-C1 and multidrug-resistant B-MD-C1 (ADR+/+) cells ($\overline{X}\pm \text{SD}$, n = 3, 48 h).

CF (μM)	Inhibitory rate (%)		EA (μM)	Inhibitory rate (%)
	B-MD-C1	B-MD-C1 (ADR +/+)		B-MD-C1	B-MD-C1 (ADR+/+)
3000	27.39 ± 4.70	22.67 ± 7.49	200	99.29 ± 5.68	99.89 ± 7.76
1000	18.62 ± 2.87	10.72 ± 3.21	100	99.52 ± 7.49	94.68 ± 10.23
333.33	5.07 ± 0.20	6.33 ± 0.35	80	78.72 ± 4.53	85.56 ± 5.62
111.11	5.30 ± 1.45	5.42 ± 2.20	60	53.30 ± 6.40	45.61 ± 4.43
37.04	2.56 ± 0.51	3.86 ± 0.49	40	6.56 ± 0.89	5.09 ± 1.35
12.35	1.36 ± 0.41	2.56 ± 0.27	20	4.01 ± 1.18	2.14 ± 1.28
4.12	1.02 ± 0.35	2.11 ± 0.45	10	3.02 ± 0.86	1.34 ± 0.57